TSPAN12 and ovarian cancer: Tspan12 knockdown in ovarian cancer disrupts the rhythmic progression through G1-S-G2/M phases, implicating its involvement in the intricate interplay of cyclins and cyclin-dependent kinases (CDKs) like Cyclin A2, D1, E2, CDK2, and CDK4 [43].